Emcure's Poviztra Cleared for Fatty Liver Treatment Following CDSCO Nod to Wegovy Written By sheeba farhat21 July 2026 9:35 PM ISTNew Delhi: Emcure Pharmaceuticals Ltd on Monday said its co-marketed brand of the innovator semaglutide, Poviztra, will now be available for the...
CDSCO Approves Novo Nordisk's Wegovy for Fatty Liver Disease in India Written By sheeba farhat19 July 2026 11:15 AM ISTNew Delhi: Novo Nordisk India on Friday said it has received approval from the Central Drugs Standard Control Organisation for indication of its...
India Approves Novo Nordisk's Wegovy for Fatty Liver Disease Written By Anshika Mishra18 July 2026 6:00 PM ISTNovo Nordisk's weight-loss drug Wegovy has received CDSCO approval in India for a new use-treating fatty liver disease (MASH). It is now the first and...
Health Bulletin 18/July/2026 Written By Anshika Mishra18 July 2026 5:16 PM ISTHere are the top health stories for the day:Rahul Gandhi Shares Alleged NEET UG Paper Rate, Calls Paper Leaks Biggest Injustice to...
India's Drug Panel Recommends Wegovy for Metabolic Liver Disease Treatment Written By Susmita Roy10 May 2026 11:45 AM ISTNew Delhi: In a significant development for the treatment of liver diseases linked to obesity and metabolic disorders, the Subject Expert Committee...
GSK's Efimosfermin Secures USFDA Breakthrough, EMA PRIME Tags for MASH Written By sheeba farhat28 April 2026 7:54 PM ISTLondon: GlaxoSmithKline plc (GSK) has announced that its investigational liver therapy efimosfermin has received both Breakthrough Therapy Designation...
Roche to acquire 89bio for up to USD 3.5 billion Written By Ruchika Sharma18 Sept 2025 11:30 AM ISTBasel: Roche has announced that it has entered into a definitive merger agreement to acquire 89bio, Inc., a publicly listed clinical-stage...
Dapagliflozin Improves MASH Without worsening liver fibrosis in new Trial Written By Dr. Shravani Dali12 Jun 2025 11:00 AM ISTResearchers have found in a randomized trial in China that dapagliflozin, an SGLT2 inhibitor, improved metabolic dysfunction-associated...
Efruxifermin Fails to Significantly Reduce Fibrosis in Compensated Cirrhosis: Study Written By Dr Riya Dave22 May 2025 8:00 AM ISTAccording to a new study published in The New England Journal of Medicine, efruxifermin, a bivalent fibroblast growth factor 21 (FGF21) analogue,...
Medical Bulletin 05/ May/ 2025 Dr. Garima Soni5 May 2025 3:00 PM ISTHere are the top medical news for the day:Too Much Chicken? New Research Finds Link to Increased Risk of Early DeathA recent study published in the...
Could a Popular Weight Loss Drug Help Treat Fatty Liver? Study Sheds Light Dr. Garima Soni5 May 2025 8:15 AM ISTA new phase 3 clinical trial published this week in The New England Journal of Medicine concludes that semaglutide, a widely used diabetes medication,...
Abnormal Thyroid Hormone Levels Independently Associated with MASH Risk: Study Written By Dr Riya Dave28 April 2025 8:00 AM ISTResearchers have discovered in a new study that abnormal serum thyroid hormone levels are independently correlated with a higher risk of metabolic...
